Дехидроксифлуорафинил

Dehydroxyfluorafinil (Modafiendz) circulated briefly in the mid-2010s as an unscheduled eugeroic. User reports describe a functional but jittery alertness that feels harsher and more stimulant-like than armodafinil or modafinil. Doses above 100 mg are poorly characterized. User reports highlight inconsistent potency, occasional tachycardia, and vasoconstriction. Formal toxicology and human pharmacokinetic studies are absent.

Also known as: Fiendz, Modafiendz

Classification

Psychoactive: Nootropic
Psychoactive: Stimulant
Tag: Benzhydryl
Tag: Diphenylmethylsulfinylacetamide
Tag: Eugeroic
Tag: Research-Chemical
Tag: Tentative

Effects

Stimulation
Increased Heart Rate
Headache
Nausea
Loss Of Appetite
Sweating
Wakefulness
Focus Enhancement
Motivation Enhancement
Thought Acceleration
Memory Enhancement
Dizziness
Appetite Suppression
Dehydration
Light Sensitivity
Photophobia
Increased Music Appreciation
Increased Libido

Routes of Administration

Oral

Dosage

Threshold: 15-25 mg
Light: 50-100 mg
Common: 100-150 mg
Strong: 150-200 mg
Heavy: 200+ mg

Duration

Onset: 0.5-1 h
Peak: 2-4 h
Offset: 2-4 h
After Effects: 6-12 h
Total Duration: 8-12 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu